Computerized Wheeze Detectors — CPB 0813 | AETNA Coverage Update

Aetna modified CPB 0813 for computerized wheeze detectors, effective December 4, 2025. Every claim tied to electronic or computerized wheeze detection is now formally classified as experimental, investigational, or unproven under Aetna billing guidelines — and that means denials.

Aetna, a CVS Health company, updated this coverage policy to explicitly exclude all uses of intermittent or continuous computerized or electronic wheeze detectors for diagnostic evaluation of lung sounds, wheezing, or cough. The policy under CPB 0813 Aetna system covers 19 ICD-10 diagnosis codes across the R05 (cough) and R06 (abnormalities of breathing) categories. If your pulmonology, allergy, or pediatrics billing team has been submitting claims for this technology — or considering it — stop now.

Quick-Reference Table

Aetna Computerized Wheeze Detector Coverage Criteria and Medical Necessity Requirements 2025

The Aetna computerized wheeze detector coverage policy is straightforward — and not in a good way for billing teams.

Aetna does not consider computerized or electronic wheeze detectors medically necessary for any indication. The policy covers both intermittent and continuous devices. It covers diagnostic use for wheezing, lung sounds, and cough.

All of it is denied.

The policy cites insufficient clinical evidence as the reason. That's the same logic Aetna applied to actigraphy and certain remote monitoring technologies in prior cycles — when evidence doesn't meet their threshold, the entire category gets the experimental label, and medical necessity arguments won't move the needle.

Prior authorization won't save these claims either. When Aetna designates a service as experimental or investigational, prior authorization is irrelevant — approval isn't available to request. Submitting a prior auth request for a service in this category wastes time and creates false confidence for your clinical team.

The reimbursement picture is equally bleak. There is no covered reimbursement pathway under this coverage policy for any computerized wheeze detection service, regardless of patient diagnosis, ordering provider, or clinical context.

Aetna Computerized Wheeze Detector Exclusions and Non-Covered Indications

This is the core of CPB 0813, and it leaves no room for interpretation.

Aetna classifies all of the following as experimental, investigational, or unproven:

The phrase "all other indications" is intentional and broad. Aetna isn't just blocking the most common use case. They're preemptively blocking any future clinical application someone might try to bill under this technology category.

This matters for practices that have been following emerging literature on wheeze detection in pediatric asthma monitoring. The clinical interest in these devices is real. Aetna's coverage policy doesn't reflect that interest — and won't until the evidence base meets their standard.

If your practice purchased or leased a computerized wheeze detection device expecting to bill Aetna patients, flag this for your compliance officer. There may be patient notification and financial exposure considerations depending on how services were presented to patients before December 4, 2025.

Coverage Indications at a Glance

Aetna Computerized Wheeze Detector Billing Guidelines and Action Items 2025

The effective date is December 4, 2025. Any claim submitted on or after that date for computerized wheeze detection under an Aetna plan runs directly into this policy.

CPT, HCPCS, and ICD-10 Codes for Computerized Wheeze Detectors Under CPB 0813

The policy data for CPB 0813 does not list specific CPT or HCPCS procedure codes. Aetna's policy exclusion is technology-category-based rather than code-specific. That means the denial rationale applies to any code used to bill computerized or electronic wheeze detection services — not just a discrete list of procedure codes.

This is actually a harder billing problem than a simple code-based exclusion. If Aetna tied the denial to specific CPT codes, you'd know exactly which lines to pull. Because the exclusion is device- and technology-based, your billing team needs to identify services by what they are, not just what code was assigned.

If you're unsure which codes your practice has been using to bill these services, pull a 12-month charge history filtered by ordering diagnosis in the R05 and R06 ranges and cross-reference with encounter notes. That's your exposure window.

Key ICD-10-CM Diagnosis Codes Listed Under CPB 0813

These are the 19 ICD-10-CM codes explicitly referenced in this coverage policy. Any claim pairing these codes with computerized wheeze detection services is subject to denial under CPB 0813.

The R05 codes cover the full spectrum of cough presentations. R06 covers a broader range of breathing abnormalities — including wheezing (R06.2), stridor (R06.1), and dyspnea (R06.0). These are common presenting diagnoses in pulmonology, allergy, and pediatric respiratory visits. The breadth of this code list signals that Aetna is drawing a wide perimeter around any potential billing attempt.